to go to the previous page
Second Cancers: Risk, Treatment Modality and Dosimetry
Wednesday, November 4, 2009
Click the plus sign to see more detailed information
about each speaker.
John Boice, Professor
, International Epidemiology Institute
John Boice is professor of Medicine at Vanderbilt University School of Medicine and scientific director of the International Epidemiology Institute (IEI). He is an international authority on radiation effects and currently serves on the Main Commission of the International Commission on Radiological Protection, the US delegation to the United Nations Scientific Committee on the Effects of Atomic Radiation, and the US Congressionally mandated Veterans' Advisory Board on Dose Reconstruction. He is a Distinguished Emeritus Member of the National Council on Radiation Protection and Measurements.
During 27 years of service in the US Public Health Service, Boice developed and became the first chief of the Radiation Epidemiology Branch at the National Cancer Institute (NCI). Boice has established programs of research in all major areas of radiation epidemiology, with major projects dealing with populations exposed to medical, occupational, military, and environmental radiation. These research efforts have aimed at clarifying cancer and other health risks associated with exposure to ionizing radiation, especially at low dose levels. Boice's seminal discoveries and over 400 publications have been used to formulate public health measures to reduce population exposure to radiation and prevent radiation associated diseases.
He currently directs the Genetic Consequences of Cancer Treatment study, supported by the NCI, the largest epidemiologic study yet undertaken to assess the possible risks of adverse pregnancy outcomes (malformation, neonatal death, stillbirth, cancer) related to the curative treatments received by cancer survivors who are able to become pregnant.
Dr. Purdy's research is directed toward 3-D treatment planning and conformal radiation therapy (3DCRT), including the development and implementation of intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT). He also is interested in the development of standards for the dose and volume specifications used in prescribing, recording and reporting radiation therapy results. Dr. Purdy is particularly interested in radiation oncology informatics, including the development of systems that can be used to receive, share and analyze volumetric multi-modality treatment planning and verification (TPV) digital data, which can be linked with clinical outcome data. He serves as the director of the Image-Guided Therapy Center (ITC), an advanced technology clinical trials quality assurance and support center supported by the National Cancer Institute (NCI).
X. George Xu received a PhD in nuclear engineering from Texas A&M University in 1994. He then joined Rensselaer Polytechnic Institute where he rose to the rank of professor in nuclear engineering. He has graduated 11 PhD and 10 M.S. students. Within AAPM, Dr. Xu has served on several committees and task groups. Dr. Xu has authored 120 peer-reviewed papers and book chapters, 160 conference abstracts, and 70 invited seminars and plenary presentations. His research has been funded by NSF, DOE, NIST, EPRI and NIH, totaling 7 million dollars including two R01 grants. Dr. Xu received a prestigious NSF Faculty CAREER Award in 1998 and a Rensselaer Research Excellence Award in 2006. Dr. Xu is also a member of the HPS, ANS, AAPM, ASTRO and CIRMS (serving as the president in 1999). In 2008, he was elected to a 6-year term as a council member of NCRP. In 2009, Dr. Xu was elected an AAPM fellow.
Harald Paganatti, Physicist, Massachusetts General Hospital
multiple presentations on the subject of secondary doses at the AAPM meeting. Supervised and participation with 4 graduate students with projects related to this topic. I also have multiple publications (12) on this topic.
Audio Synchronized to PowerPoint